These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 33436820)
21. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis. Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048 [TBL] [Abstract][Full Text] [Related]
22. An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes. Győrffy B; Pongor L; Bottai G; Li X; Budczies J; Szabó A; Hatzis C; Pusztai L; Santarpia L Br J Cancer; 2018 Apr; 118(8):1107-1114. PubMed ID: 29559730 [TBL] [Abstract][Full Text] [Related]
23. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer. Li W; Sang M; Hao X; Jia L; Wang Y; Shan B J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586 [TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
25. Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells. Hermawan A; Putri H Asian Pac J Cancer Prev; 2020 Sep; 21(9):2751-2762. PubMed ID: 32986377 [TBL] [Abstract][Full Text] [Related]
26. Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients. Zhang J; Abrams Z; Parvin JD; Huang K BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):513. PubMed ID: 27556157 [TBL] [Abstract][Full Text] [Related]
27. Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer. Chereda H; Bleckmann A; Menck K; Perera-Bel J; Stegmaier P; Auer F; Kramer F; Leha A; Beißbarth T Genome Med; 2021 Mar; 13(1):42. PubMed ID: 33706810 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis. Wu D; Han B; Guo L; Fan Z J Obstet Gynaecol; 2016 Jul; 36(5):615-21. PubMed ID: 26804550 [TBL] [Abstract][Full Text] [Related]
29. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach. Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607 [TBL] [Abstract][Full Text] [Related]
30. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis. Li A; Chapuy B; Varelas X; Sebastiani P; Monti S Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402 [TBL] [Abstract][Full Text] [Related]
31. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration. Zhang W; Wang SL Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714 [TBL] [Abstract][Full Text] [Related]
32. NetMix2: A Principled Network Propagation Algorithm for Identifying Altered Subnetworks. Chitra U; Park TY; Raphael BJ J Comput Biol; 2022 Dec; 29(12):1305-1323. PubMed ID: 36525308 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data. Hua Y; Gao L; Li X Pathol Oncol Res; 2021; 27():1609789. PubMed ID: 34408553 [No Abstract] [Full Text] [Related]
34. Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer. Li Y; Guo M; Fu Z; Wang P; Zhang Y; Gao Y; Yue M; Ning S; Li D Oncotarget; 2017 Jan; 8(2):2444-2456. PubMed ID: 27911271 [TBL] [Abstract][Full Text] [Related]
35. NoMAS: A Computational Approach to Find Mutated Subnetworks Associated With Survival in Genome-Wide Cancer Studies. Altieri F; Hansen TV; Vandin F Front Genet; 2019; 10():265. PubMed ID: 31024613 [TBL] [Abstract][Full Text] [Related]
37. OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine. López-Cortés A; Paz-Y-Miño C; Guerrero S; Cabrera-Andrade A; Barigye SJ; Munteanu CR; González-Díaz H; Pazos A; Pérez-Castillo Y; Tejera E Sci Rep; 2020 Mar; 10(1):5285. PubMed ID: 32210335 [TBL] [Abstract][Full Text] [Related]
38. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743 [TBL] [Abstract][Full Text] [Related]
39. Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information. Yue Z; Li HT; Yang Y; Hussain S; Zheng CH; Xia J; Chen Y Oncotarget; 2016 Jun; 7(24):36092-36100. PubMed ID: 27150055 [TBL] [Abstract][Full Text] [Related]
40. IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer. Mounika Inavolu S; Renbarger J; Radovich M; Vasudevaraja V; Kinnebrew GH; Zhang S; Cheng L CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):168-176. PubMed ID: 28266149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]